global8k.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Washington, DC 20549



Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) 
December 9, 2008

(Exact name of registrant as specified in its charter)

Colorado 0-22083 84-1116894
(State or other jurisdiction of (Commission File No.) (I.R.S. Employer
incorporation or organization) Identification No.)
12600 West Colfax, Suite C-420, Lakewood, Colorado 80215
(Address of principal executive offices) (Zip Code)
(303) 238-2000
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the 
registrant under any of the following provisions: 
¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Item 8.01.          Other Events.

On December 9, 2008, Global Med Technologies, Inc. issued a press release with respect to its receipt of an unsolicited proposal from Victory Park Capital Advisors, LLC. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01.          Financial Statements and Exhibits.

              (a)      Not applicable
(b)      Not applicable
(c)      Not applicable
(d)      Exhibits.
  99.1           Press Release dated December 9, 2008

- 2 -


     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GLOBAL MED TECHNOLOGIES, INC.                             
        By:     /s/  Michael I. Ruxin, M.D. 
                   Michael I. Ruxin, M.D. 
                   Chairman and Chief Executive Officer         
Date:    December 9, 2008         

- 3 -

Exhibit Index

Exhibit No. Description                                                                                                           
99.1      Press Release dated December 9, 2008


- 4 -